2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Aleandri S et al. Design of Light-Triggered Lyotropic Liquid Crystal Mesophases and Their Application as Molecular Switches in "On Demand" Release. 2015 Langmuir pmid:26039728
Pluhackova K et al. Extension of the LOPLS-AA Force Field for Alcohols, Esters, and Monoolein Bilayers and its Validation by Neutron Scattering Experiments. 2015 J Phys Chem B pmid:26537654
Wibroe PP et al. Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers. 2015 Nanomedicine pmid:26348655
Rosa A et al. Monoolein-based cubosomes affect lipid profile in HeLa cells. 2015 Chem. Phys. Lipids pmid:26341749
Pham AC et al. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging. 2015 Drug Deliv Transl Res pmid:26328930
Gonçalves VSS et al. Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles. 2015 Int J Pharm pmid:26277371
Mohamed AI et al. In-vivo evaluation of clindamycin release from glyceryl monooleate-alginate microspheres by NIR spectroscopy. 2015 Int J Pharm pmid:26276253
Oliveira AC et al. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells. 2015 Acta Biomater pmid:26225736
Luo Q et al. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake. 2015 Int J Pharm pmid:26209071
Kumar M and Kumaraswamy G Phase behaviour of the ternary system: monoolein-water-branched polyethylenimine. 2015 Soft Matter pmid:26081120
Réeff J et al. Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. 2015 Int J Pharm pmid:25934426
Borgheti-Cardoso LN et al. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. 2015 Eur J Pharm Sci pmid:25917525
Murgia S et al. Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. 2015 Colloids Surf B Biointerfaces pmid:25829131
Ruocco N et al. How hydrophobically modified chitosans are stabilized by biocompatible lipid aggregates. 2015 J Colloid Interface Sci pmid:25935287
Tyler AI et al. Electrostatic swelling of bicontinuous cubic lipid phases. 2015 Soft Matter pmid:25790335
Rachmawati H et al. Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study. 2015 AAPS PharmSciTech pmid:25511810
Barriga HM et al. Temperature and pressure tuneable swollen bicontinuous cubic phases approaching nature's length scales. 2015 Soft Matter pmid:25430049
Salvati Manni L et al. Phase behavior of a designed cyclopropyl analogue of monoolein: implications for low-temperature membrane protein crystallization. 2015 Angew. Chem. Int. Ed. Engl. pmid:25418121
Bhatt AB et al. Silica nanoparticle stabilization of liquid crystalline lipid dispersions: impact on enzymatic digestion and drug solubilization. 2015 Curr Drug Deliv pmid:25176029
Rachmawati H et al. Curcumin nanoemulsion for transdermal application: formulation and evaluation. 2015 Drug Dev Ind Pharm pmid:24502271